OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OPRX

<< 前へ 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/02/03	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/02/03	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/02/03	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/02/03	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/02/03	07 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/19	06 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/13	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/13	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/13	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/10	22 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2018/01/09	06 : 33	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OPRX	OptimizeRx Corporation
2017/12/07	22 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/11/23	06 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/11/16	22 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/11/07	04 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/11/03	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/11/03	05 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/20	02 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/06	21 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/03	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/03	04 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/03	04 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2017/10/03	04 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPRX	OptimizeRx Corporation
2017/09/27	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/09/13	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/09/06	05 : 39	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/09/02	05 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/08/11	05 : 22	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OPRX	OptimizeRx Corporation
2017/08/03	23 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation
2017/08/02	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPRX	OptimizeRx Corporation